Recently, the Alliance for Patient Access (AfPA) published a blog titled Prescription Digital Therapeutics Emerge as Health Care’s Newest Frontier. The blog highlights how prescription digital therapeutics (PDTs) work and their potentially uncertain path ahead. Specifically, the blog explains that PDTs are therapeutics that are prescribed by providers as a form of treatment for a wide variety of conditions such as chronic insomnia, diabetes, congestive heart failure, dementia, and Alzheimer’s disease. The blog also addresses the lack of coverage for PDTs by both private plans and Medicare. The full blog can be read here.
Aimed Alliance spearheads ACTION for PDTs, multidisciplinary partnership that is working to expand the adoption, coverage, and access to PDTs for individuals with chronic diseases. To learn more about ACTION for PDT’s upcoming work, click here.